Jason R. Dinges

Jason R. Dinges, Ph.D., is an investment advisor at Morningside Technology Advisory LLC, which he joined in 2011. He has extensive experience providing operational and management oversight to early-stage biotechnology companies. Jason is a director of several biopharmaceutical/biotechnology companies across a broad spectrum of therapeutic areas including Kezar Life Sciences, Enyo Pharma, CellCentric, Cognito Therapeutics, Cancer Targeting Systems, Matatu, Bacainn Biotherapeutics, ClearB Therapeutics, Apic Bio and Allysta Pharmaceuticals. He has also facilitated multiple financings for private companies. From 2006 to 2011, Jason was an associate attorney at Foley & Lardner LLP practicing intellectual property law in the firm’s chemical, biotechnology and pharmaceutical practice group. He received his doctorate in genetics from Iowa State University and his juris doctorate, with highest distinction, from the University of Iowa College of Law.